SELDI-TOF-MS proteomics of breast cancer (Q33227849)

24 July 2017

1 reference

title

SELDI-TOF-MS proteomics of breast cancer (English)

1 reference

24 July 2017

1 reference

Charlotte H Clarke

1

1 reference

PubMed ID

16309366

24 July 2017

Julie A Buckley

series ordinal

2

1 reference

PubMed ID

16309366

24 July 2017

Eric T Fung

series ordinal

3

1 reference

24 July 2017

1 January 2005

1 reference

Clinical Chemistry and Laboratory Medicine

24 July 2017

1 reference

24 July 2017

43

1 reference

24 July 2017

12

1 reference

24 July 2017

1314-1320

1 reference

Classification of cancer types by measuring variants of host response proteins using SELDI serum assays

24 July 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

The application of 2D gel-based proteomics methods to the study of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Understanding mathematical models for breast cancer risk assessment and counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Use of proteomic analysis to monitor responses to biological therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimens using surface-enhanced laser desorption and ionization-time of flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Prognostic molecular markers in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Clinical applications of proteomics: proteomic pattern diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Bioinformatics meets proteomics--bridging the gap between mass spectrometry data analysis and cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Serum tumor markers in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Mass spectral analysis in proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Proteomic patterns for early cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Current developments in SELDI affinity technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Proteomics and cancer diagnosis: the potential of mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Bioinformatics strategies for proteomic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

Serum proteomics profiling—a young technology begins to mature

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2005.225

21 January 2018

Identifiers

DOI

10.1515/CCLM.2005.225

1 reference

24 July 2017

1 reference

PubMed ID

16309366